{"id":"SCV000187678","clinical_assertion_trait_set_id":"SCV000187678","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}}}","submission_id":"505267.2014-07-16","version":"1","internal_id":"339358","clinical_assertion_observation_ids":["SCV000187678.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6607","date_created":"2014-11-11","submitter_id":"505267","rcv_accession_id":"RCV000144921","submission_names":[],"local_key":"rs1801133","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000884146","clinical_assertion_trait_set_id":"SCV000884146","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2018-07-13","version":"2","internal_id":"1730401","clinical_assertion_observation_ids":["SCV000884146.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2019-02-15","submitter_id":"25969","rcv_accession_id":"RCV000428048","submission_names":["Aug 2019 ARUP"],"local_key":"74380|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000268236","clinical_assertion_trait_set_id":"SCV000268236","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981204929\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20638924\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503703","clinical_assertion_observation_ids":["SCV000268236.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26869","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211133","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981204929PA449165|cyclophosphamide response - Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000268238","clinical_assertion_trait_set_id":"SCV000268238","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981220481\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19307503\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21605004\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503705","clinical_assertion_observation_ids":["SCV000268238.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26870","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211336","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981220481PA448803|carboplatin response - Efficacy","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000891532","clinical_assertion_trait_set_id":"SCV000891532","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"16432849\",\"@Source\":\"PubMed\"}}}}","submission_id":"506653.2018-10-25","interpretation_date_last_evaluated":"2017-12-30","version":"1","internal_id":"1747332","clinical_assertion_observation_ids":["SCV000891532.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6404","date_created":"2019-03-21","submitter_id":"506653","rcv_accession_id":"RCV000761447","submission_names":["SUB4684823"],"local_key":"NM_005957.4:c.665C\u003eT|OMIM:188050","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000494694","clinical_assertion_trait_set_id":"SCV000494694","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/827848365\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11418485\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12453860\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12915598\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14647408\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15781665\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16013960\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16019535\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16462575\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16463153\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16501586\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16870553\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17180579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17323057\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17488658\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17512587\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18458567\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18987660\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19648163\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21644011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21747412\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22143415\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22838948\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23089671\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23488607\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23648444\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23775025\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24241962\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24637499\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25007187\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25065700\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25110820\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25303299\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25778468\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26014925\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27399166\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28696419\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29683944\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2018-05-14","version":"2","internal_id":"967913","clinical_assertion_observation_ids":["SCV000494694.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"35046","date_created":"2017-02-17","submitter_id":"500295","rcv_accession_id":"RCV000417131","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"827848365PA450428|methotrexate response - Dosage, Efficacy, Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000505736","clinical_assertion_trait_set_id":"SCV000505736","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000376592:c.665C\u003eT\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"18704422\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-03-10","version":"1","internal_id":"971011","clinical_assertion_observation_ids":["SCV000505736.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion provided","trait_set_id":"6728","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000427078","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000376592:c.665C\u003eT|MeSH:D013274","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"not provided","variation_id":"3520"}
{"id":"SCV000519504","clinical_assertion_trait_set_id":"SCV000519504","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2016-04-25","version":"4","internal_id":"984917","clinical_assertion_observation_ids":["SCV000519504.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-03-03","submitter_id":"26957","rcv_accession_id":"RCV000428048","submission_names":["SUB3839901"],"local_key":"GDX:570299|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000203040","clinical_assertion_trait_set_id":"SCV000203040","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MTHFR\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2017-01-13","version":"7","internal_id":"361011","clinical_assertion_observation_ids":["SCV000203040.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2015-01-28","submitter_id":"500060","rcv_accession_id":"RCV000153516","submission_names":["SUB4534263"],"local_key":"8162_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"other","variation_id":"3520"}
{"id":"SCV001135171","clinical_assertion_trait_set_id":"SCV001135171","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","submission_id":"500035.2019-10-22","interpretation_date_last_evaluated":"2019-05-28","version":"1","internal_id":"2240970","clinical_assertion_observation_ids":["SCV001135171.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2020-01-07","submitter_id":"500035","rcv_accession_id":"RCV000259890","submission_names":["MENDELICS_CLINVAR_020"],"local_key":"NC_000001.10:g.11856378G\u003eA|OMIM:601634","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV001147149","clinical_assertion_trait_set_id":"SCV001147149","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submission_id":"505870.2019-07-12","interpretation_date_last_evaluated":"2016-10-01","version":"1","internal_id":"2265337","clinical_assertion_observation_ids":["SCV001147149.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-30","submitter_id":"505870","rcv_accession_id":"RCV000153516","submission_names":["2019-07"],"local_key":":Chr.1_11856378_11856378_G_A|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000023860","clinical_assertion_trait_set_id":"SCV000023860","submission_id":"3.2015-03-10","interpretation_date_last_evaluated":"2019-06-11","version":"6","internal_id":"23860","clinical_assertion_observation_ids":["SCV000023860.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","title":"MTHFR, 677C-T, ALA222VAL (rs1801133)_MTHFR THERMOLABILE POLYMORPHISM","trait_set_id":"916","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000003697","submission_names":[],"local_key":"607093.0003_MTHFR THERMOLABILE POLYMORPHISM","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000106043","clinical_assertion_trait_set_id":"SCV000106043","submission_id":"256489.2017-03-08","version":"1","internal_id":"183447","clinical_assertion_observation_ids":["SCV000106043.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"916","date_created":"2013-11-19","submitter_id":"256489","rcv_accession_id":"RCV000003697","submission_names":["FirmaLab_clinical_tests_from_GTR"],"local_key":"NM_005957.4:c.665C\u003eT|MedGen:C1856059","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"3520"}
{"id":"SCV000347807","clinical_assertion_trait_set_id":"SCV000347807","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"661330","clinical_assertion_observation_ids":["SCV000347807.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000259890","submission_names":["ICSL_2016Q4"],"local_key":"361|Neural Tube Defects, Folate-Sensitive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV000549301","clinical_assertion_trait_set_id":"SCV000549301","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2019-11-25","version":"6","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"date_last_updated":"2020-04-15","assertion_type":"variation to disease","variation_archive_id":"VCV000037594","review_status":"criteria provided, single submitter","trait_set_id":"7920","date_created":"2017-04-13","submitter_id":"500031","rcv_accession_id":"RCV000458634","submission_names":["SUB6933778"],"local_key":"676082|MedGen:C0677776","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"37594"}
{"id":"SCV001119032","clinical_assertion_trait_set_id":"SCV001119032","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2086965","clinical_assertion_observation_ids":["SCV001119032.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-14","submitter_id":"500031","rcv_accession_id":"RCV000727222","submission_names":["SUB6897608"],"local_key":"2035389|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV001144884","clinical_assertion_trait_set_id":"SCV001144884","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27208204\",\"@Source\":\"PubMed\"}}}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-03-14","version":"1","internal_id":"2256633","clinical_assertion_observation_ids":["SCV001144884.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000727222","submission_names":["SUB6347501"],"local_key":"2853148|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV001157178","clinical_assertion_trait_set_id":"SCV001157178","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2019-06-26","version":"1","internal_id":"2281510","clinical_assertion_observation_ids":["SCV001157178.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2020-02-07","submitter_id":"25969","rcv_accession_id":"RCV000039762","submission_names":["Aug 2019 ARUP"],"local_key":"121670|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV000063451","clinical_assertion_trait_set_id":"SCV000063451","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2017-09-04","version":"6","internal_id":"104651","clinical_assertion_observation_ids":["SCV000063451.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000039762","submission_names":["SUB5348979"],"local_key":"30968208|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000706730","clinical_assertion_trait_set_id":"SCV000706730","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCDH15\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2018-05-30","version":"2","internal_id":"1379128","clinical_assertion_observation_ids":["SCV000706730.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000727222","submission_names":["SUB4534263"],"local_key":"60128_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000729392","clinical_assertion_trait_set_id":"SCV000729392","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2017-11-21","version":"1","internal_id":"1410550","clinical_assertion_observation_ids":["SCV000729392.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-04-04","submitter_id":"26957","rcv_accession_id":"RCV000039762","submission_names":["SUB3839901"],"local_key":"GDX:46979|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000363106","clinical_assertion_trait_set_id":"SCV000363106","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676628","clinical_assertion_observation_ids":["SCV000363106.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000326661","submission_names":["ICSL_2016Q4"],"local_key":"165026|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000363107","clinical_assertion_trait_set_id":"SCV000363107","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676629","clinical_assertion_observation_ids":["SCV000363107.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","date_created":"2016-12-02","submitter_id":"504895","submission_names":["ICSL_2016Q4"],"local_key":"165026|Usher Syndrome","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV001144806","clinical_assertion_trait_set_id":"SCV001144806","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20146813\",\"@Source\":\"PubMed\"}}]}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-05-14","version":"1","internal_id":"2256555","clinical_assertion_observation_ids":["SCV001144806.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000726979","submission_names":["SUB6347501"],"local_key":"2854484|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000065162","clinical_assertion_trait_set_id":"SCV000065162","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2018-08-21","version":"6","internal_id":"106362","clinical_assertion_observation_ids":["SCV000065162.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000041467","submission_names":["SUB5348979"],"local_key":"11832988|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000704632","clinical_assertion_trait_set_id":"SCV000704632","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OTOF\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2016-12-20","version":"2","internal_id":"1377031","clinical_assertion_observation_ids":["SCV000704632.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000726979","submission_names":["SUB4534263"],"local_key":"57851_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000429634","clinical_assertion_trait_set_id":"SCV000429634","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"743155","clinical_assertion_observation_ids":["SCV000429634.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000357820","submission_names":["ICSL_2016Q4"],"local_key":"231996|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV001037250","clinical_assertion_trait_set_id":"SCV001037250","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2005121","clinical_assertion_observation_ids":["SCV001037250.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000007884","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-11","submitter_id":"500031","rcv_accession_id":"RCV000078671","submission_names":["SUB6897608"],"local_key":"2281434|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"7884"}
{"id":"SCV000504294","clinical_assertion_trait_set_id":"SCV000504294","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969570","clinical_assertion_observation_ids":["SCV000504294.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"11864","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000443065","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D001932","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504300","clinical_assertion_trait_set_id":"SCV000504300","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969576","clinical_assertion_observation_ids":["SCV000504300.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"9305","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000418680","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015451","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504293","clinical_assertion_trait_set_id":"SCV000504293","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969569","clinical_assertion_observation_ids":["SCV000504293.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"35132","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000433779","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D018268","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504295","clinical_assertion_trait_set_id":"SCV000504295","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14679157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18794803\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2015-07-14","version":"1","internal_id":"969571","clinical_assertion_observation_ids":["SCV000504295.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"12074","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000426339","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D008545","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000504299","clinical_assertion_trait_set_id":"SCV000504299","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969575","clinical_assertion_observation_ids":["SCV000504299.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"1717","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000435875","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C535575","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504298","clinical_assertion_trait_set_id":"SCV000504298","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969574","clinical_assertion_observation_ids":["SCV000504298.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"3349","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000426107","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C538231","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504296","clinical_assertion_trait_set_id":"SCV000504296","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969572","clinical_assertion_observation_ids":["SCV000504296.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"35142","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000437006","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MedGen:C0279680","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504291","clinical_assertion_trait_set_id":"SCV000504291","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19537845\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22310681\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20619739\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21129611\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20350999\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969567","clinical_assertion_observation_ids":["SCV000504291.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"31428","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000443882","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015179","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000504292","clinical_assertion_trait_set_id":"SCV000504292","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969568","clinical_assertion_observation_ids":["SCV000504292.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"6369","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000423919","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C562393","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504297","clinical_assertion_trait_set_id":"SCV000504297","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969573","clinical_assertion_observation_ids":["SCV000504297.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"6478","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000442759","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D009101","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000035262","clinical_assertion_trait_set_id":"SCV000035262","submission_id":"3.2010-12-30","interpretation_date_last_evaluated":"2003-11-17","version":"6","internal_id":"35262","clinical_assertion_observation_ids":["SCV000035262.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","title":"BRAF, ASP594GLY_LYMPHOMA, NON-HODGKIN, SOMATIC","trait_set_id":"3352","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000015006","submission_names":[],"local_key":"164757.0011_LYMPHOMA, NON-HODGKIN, SOMATIC","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000061597","clinical_assertion_trait_set_id":"SCV000061597","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2012-06-11","version":"4","internal_id":"102797","clinical_assertion_observation_ids":["SCV000061597.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"criteria provided, single submitter","trait_set_id":"4069","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000037932","submission_names":["SUB5348977"],"local_key":"15072993|MeSH:D002289","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, end ometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000883121","clinical_assertion_trait_set_id":"SCV000883121","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"506039.2018-11-26","interpretation_date_last_evaluated":"2018-11-21","version":"1","internal_id":"1729239","clinical_assertion_observation_ids":["SCV000883121.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2019-02-15","submitter_id":"506039","rcv_accession_id":"RCV000020088","submission_names":["SUB4842992"],"local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000602533","clinical_assertion_trait_set_id":"SCV000602533","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2018-10-10","interpretation_date_last_evaluated":"2018-06-20","version":"2","internal_id":"1166229","clinical_assertion_observation_ids":["SCV000602533.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-09-27","submitter_id":"25969","rcv_accession_id":"RCV000034388","submission_names":["SUB4618058"],"local_key":"11931|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"822"}
{"id":"SCV000600091","clinical_assertion_trait_set_id":"SCV000600091","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29478780\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29506128\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30487145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500110.2020-03-06","interpretation_date_last_evaluated":"2019-08-04","version":"2","internal_id":"1163765","clinical_assertion_observation_ids":["SCV000600091.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-09-27","submitter_id":"500110","rcv_accession_id":"RCV000034388","submission_names":["SUB6975398"],"local_key":"2564206|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000610138","clinical_assertion_trait_set_id":"SCV000610138","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505698.2017-10-05","interpretation_date_last_evaluated":"2017-07-27","version":"1","internal_id":"1190191","clinical_assertion_observation_ids":["SCV000610138.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-11-02","submitter_id":"505698","rcv_accession_id":"RCV000034388","submission_names":[],"local_key":"19388615","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000148996","clinical_assertion_trait_set_id":"SCV000148996","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-09-07","interpretation_date_last_evaluated":"2015-05-08","version":"4","internal_id":"269650","clinical_assertion_observation_ids":["SCV000148996.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2014-05-13","submitter_id":"26957","rcv_accession_id":"RCV000034388","submission_names":["SUB4498316"],"local_key":"GDX:3786|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000153895","clinical_assertion_trait_set_id":"SCV000153895","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500031.2019-03-28","interpretation_date_last_evaluated":"2019-01-14","version":"9","internal_id":"279290","clinical_assertion_observation_ids":["SCV000153895.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2014-06-03","submitter_id":"500031","rcv_accession_id":"RCV000020088","submission_names":["SUB5371970"],"local_key":"7840|MedGen:C2713442","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000084184","clinical_assertion_trait_set_id":"SCV000084184","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\"}}","submission_id":"504914.2014-05-29","interpretation_date_last_evaluated":"2013-09-19","version":"1","internal_id":"281153","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion provided","trait_set_id":"9590","date_created":"2014-06-09","submitter_id":"504914","rcv_accession_id":"RCV000120049","submission_names":["Cancer_genes_01"],"local_key":"MedGen:CN169374","interpretation_comments":[],"record_status":"current","interpretation_description":"not provided","variation_id":"822"}
{"id":"SCV000297021","clinical_assertion_trait_set_id":"SCV000297021","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","submission_id":"165021.2016-01-06","interpretation_date_last_evaluated":"2015-11-24","version":"2","internal_id":"574598","clinical_assertion_observation_ids":["SCV000297021.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"8942","date_created":"2016-07-29","submitter_id":"165021","rcv_accession_id":"RCV000238802","submission_names":["exome2015-12-22"],"local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV001154466","clinical_assertion_trait_set_id":"SCV001154466","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submission_id":"505870.2019-07-12","interpretation_date_last_evaluated":"2019-05-01","version":"1","internal_id":"2272833","clinical_assertion_observation_ids":["SCV001154466.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-31","submitter_id":"505870","rcv_accession_id":"RCV000034388","submission_names":["2019-07"],"local_key":":Chr.5_112175211_112175211_T_A|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000805404","clinical_assertion_trait_set_id":"SCV000805404","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"239772.2018-01-29","interpretation_date_last_evaluated":"2016-01-06","version":"1","internal_id":"1570355","clinical_assertion_observation_ids":["SCV000805404.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-09-12","submitter_id":"239772","rcv_accession_id":"RCV000034388","submission_names":["SUB3589995"],"local_key":"NM_000038.5:c.3920T\u003eA|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000677724","clinical_assertion_trait_set_id":"SCV000677724","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","submission_id":"320494.2017-06-22","interpretation_date_last_evaluated":"2016-09-27","version":"1","internal_id":"1328882","clinical_assertion_observation_ids":["SCV000677724.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-01-04","submitter_id":"320494","rcv_accession_id":"RCV000020088","submission_names":["SUB2805501"],"local_key":"76464|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\"}"],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000807826","clinical_assertion_trait_set_id":"SCV000807826","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"1024.2018-07-17","interpretation_date_last_evaluated":"2018-06-01","version":"1","internal_id":"1575248","clinical_assertion_observation_ids":["SCV000807826.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"35108","date_created":"2018-09-20","submitter_id":"1024","rcv_accession_id":"RCV000680453","submission_names":["SUB4304907"],"local_key":"APC-B1|MedGen:CN240755","submitted_assembly":"GRCh38","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000838110","clinical_assertion_trait_set_id":"SCV000838110","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","submission_id":"500035.2018-11-11","interpretation_date_last_evaluated":"2018-07-02","version":"2","internal_id":"1610680","clinical_assertion_observation_ids":["SCV000838110.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-10-05","submitter_id":"500035","rcv_accession_id":"RCV000020088","submission_names":["MENDELICS_CLINVAR_015"],"local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000821694","clinical_assertion_trait_set_id":"SCV000821694","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505504.2020-03-06","interpretation_date_last_evaluated":"2020-01-01","version":"2","internal_id":"1609757","clinical_assertion_observation_ids":["SCV000821694.0"],"date_last_updated":"2020-04-22","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2018-10-05","submitter_id":"505504","rcv_accession_id":"RCV000115087","submission_names":["SUB6775616"],"local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces Isoleucine with Lysine at codon 1307 of the APC protein. The isoleucine residue is mildly conserved among species and is located in a known functional domain of the protein. There is a big physiochemical difference between isoleucine and lysine (Grantham Score 102). This variant is listed in population databases (rs1801155, ExAC 0.3) and is a common finding in individuals of Ashkenazi (~6-10%) and Sephardic Jewish decent (~3%; PMID: 9288102 ,23896379 ).Multiple studies have associated this variant with a moderate increase in the risk of colorectal cancer in individuals of Ashkenazi Jewish ancestry, in whom this variant is identified in 28% of cases with familial colorectal cancer (PMID: 9288102 ). In a recent meta-analysis the risk of colorectal cancer development was estimated to be increased 2-fold in Ashkenazi Jewish individuals carrying this variant, while this increase was not evident in other populations (PMID: 23576677). The mutation database ClinVar contains multiple entries for this variant (Variation ID:822).\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000021015","clinical_assertion_trait_set_id":"SCV000021015","submission_id":"3.2010-12-30","interpretation_date_last_evaluated":"2003-12-01","version":"3","internal_id":"21015","clinical_assertion_observation_ids":["SCV000021015.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to included disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","trait_set_id":"216","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000000865","submission_names":[],"local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000021014","clinical_assertion_trait_set_id":"SCV000021014","submission_id":"3.2014-02-19","interpretation_date_last_evaluated":"2019-04-01","version":"3","internal_id":"21014","clinical_assertion_observation_ids":["SCV000021014.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","trait_set_id":"215","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000000864","submission_names":[],"local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000839876","clinical_assertion_trait_set_id":"SCV000839876","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"500199.2018-06-14","interpretation_date_last_evaluated":"2017-06-02","version":"1","internal_id":"1637429","clinical_assertion_observation_ids":["SCV000839876.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-10-11","submitter_id":"500199","rcv_accession_id":"RCV000020088","submission_names":["SUB4151980"],"local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000183892","clinical_assertion_trait_set_id":"SCV000183892","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}}]}}","submission_id":"61756.2020-02-26","interpretation_date_last_evaluated":"2019-02-28","version":"7","internal_id":"302407","clinical_assertion_observation_ids":["SCV000183892.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2014-08-01","submitter_id":"61756","rcv_accession_id":"RCV000115087","submission_names":["NonExomeUpdate_101019AmbryReport"],"local_key":"a4793","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Significant disease association in appropriately sized case-control study(ies);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Other strong data supporting pathogenic classification\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"822"}
{"id":"SCV000686956","clinical_assertion_trait_set_id":"SCV000686956","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505849.2018-11-06","interpretation_date_last_evaluated":"2018-05-21","version":"2","internal_id":"1344252","clinical_assertion_observation_ids":["SCV000686956.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2018-02-16","submitter_id":"505849","rcv_accession_id":"RCV000115087","submission_names":["SUB4721021"],"local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000043125","clinical_assertion_trait_set_id":"SCV000043125","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","submission_id":"1160.2012-07-15","interpretation_date_last_evaluated":"2012-07-13","version":"1","internal_id":"98286","clinical_assertion_observation_ids":["SCV000043125.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","trait_set_id":"9460","date_created":"2013-03-26","submitter_id":"1160","rcv_accession_id":"RCV000034388","submission_names":["ClinSeq_cancer"],"local_key":"NM_000038.4:c.3920T\u003eA|not provided","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"],"record_status":"current","interpretation_description":"variant of unknown significance","variation_id":"822"}
{"id":"SCV000693480","clinical_assertion_trait_set_id":"SCV000693480","submission_id":"506273.2017-11-15","interpretation_date_last_evaluated":"2017-11-10","version":"1","internal_id":"1359177","clinical_assertion_observation_ids":["SCV000693480.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","trait_set_id":"13598","date_created":"2018-03-01","submitter_id":"506273","rcv_accession_id":"RCV000115087","submission_names":["SUB3222006"],"local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000853088","clinical_assertion_trait_set_id":"SCV000853088","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","submission_id":"506211.2018-10-29","interpretation_date_last_evaluated":"2017-01-01","version":"1","internal_id":"1663716","clinical_assertion_observation_ids":["SCV000853088.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"1735","date_created":"2018-11-21","submitter_id":"506211","rcv_accession_id":"RCV000722046","submission_names":["SUB4705375"],"local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000694042","clinical_assertion_trait_set_id":"SCV000694042","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27978560\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28050010\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25604157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10679643\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15929773\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11207040\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28749474\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30426508\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26187149\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500026.2019-09-24","interpretation_date_last_evaluated":"2019-08-27","version":"2","internal_id":"1360394","clinical_assertion_observation_ids":["SCV000694042.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-03-15","submitter_id":"500026","rcv_accession_id":"RCV000120049","submission_names":["SUB6341163"],"local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN169374","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: APC c.3920T\u003eA (p.Ile1307Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 251040 control chromosomes in the gnomAD database (exomes dataset), predominantly found within the Ashkenazi Jewish subpopulation at a frequency of 0.036, including 7 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 500 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis (FAP) phenotype (7.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Ashkenazi Jewish origin. The variant, c.3920T\u003eA, has been reported in the literature in multiple individuals affected with colorectal cancer (CRC) and other tumor phenotypes, however in some of these cases it was also reported to co-occur with other pathogenic variants (Yurgelun_2017 and Simbolo_2015). Multiple case-control studies (Abdel-Malak_2016, Drucker_2000, Fidder_2005, Gryfe_1998, Laken_1997, Leshno_2016, and Shtoyerman-Chen_2001), demonstrated that this variant is associated with a moderately increased risk for CRC in Ashkenazi Jewish population. A large meta-analysis concluded that the variant increases the risk about two-fold for CRC in individuals of Ashkenazi Jewish ancestry (OR=2.17, 95% CI=1.65-2.86), however it does not appear to confer an additional risk for CRC in non-Ashkenazi cases (Liang_2013). A recent case-control study involving a large Israeli cohort indicated that this variant might be also associated with a significantly higher risk for non-CRC cancers, with the APC I1307K variant being proposed as a reliable marker for overall cancer risk (OR=2.53) (Leshno_2016). The A8 mononucleotide tract created by this germline change has been shown to confer an increased propensity for generating somatic frameshift mutations on this allele, leading to a loss of function of APC that constitutes an important somatic event in tumor initiation (Gryfe_1998; Laken_1997). 19 other submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments, with 7 reporting it as a risk factor. Taken together, this polymorphic variant is associated with a modestly increased risk for CRC in the Ashkenazi Jewish population, but is not associated with FAP or AFAP. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.\"}"],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000266006","clinical_assertion_trait_set_id":"SCV000266006","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"506834.2016-03-03","interpretation_date_last_evaluated":"2015-11-20","version":"1","internal_id":"498299","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"1570","date_created":"2016-03-19","submitter_id":"506834","rcv_accession_id":"RCV000210085","submission_names":["GIM_BROCA"],"local_key":"c.3920T\u003eA","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000591159","clinical_assertion_trait_set_id":"SCV000591159","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","submission_id":"506152.2017-04-19","interpretation_date_last_evaluated":"2016-08-15","version":"1","internal_id":"1147603","clinical_assertion_observation_ids":["SCV000591159.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-08-25","submitter_id":"506152","rcv_accession_id":"RCV000120049","submission_names":["SHS20170111"],"local_key":"NM_000038.5:c.3920T\u003eA|not specified","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000040392","clinical_assertion_trait_set_id":"SCV000040392","submission_id":"500062.2013-01-08","interpretation_date_last_evaluated":"2011-10-27","version":"1","internal_id":"40392","clinical_assertion_observation_ids":["SCV000040392.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","trait_set_id":"6265","date_created":"2011-05-06","submitter_id":"500062","rcv_accession_id":"RCV000020088","submission_names":[],"local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\"}"],"record_status":"current","interpretation_description":"pathologic","variation_id":"822"}
{"id":"SCV000076444","clinical_assertion_trait_set_id":"SCV000076444","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2020-01-19","version":"12","internal_id":"124374","clinical_assertion_observation_ids":["SCV000076444.0"],"date_last_updated":"2020-04-15","assertion_type":"variation to disease","variation_archive_id":"VCV000017674","review_status":"criteria provided, single submitter","trait_set_id":"7920","date_created":"2013-07-02","submitter_id":"500031","rcv_accession_id":"RCV000048431","submission_names":["SUB6933801"],"local_key":"306942|MedGen:C0677776","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"17674"}
{"id":"SCV000788260","clinical_assertion_trait_set_id":"SCV000788260","content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","submission_id":"506018.2018-05-10","interpretation_date_last_evaluated":"2018-05-04","version":"1","internal_id":"1538355","clinical_assertion_observation_ids":["SCV000788260.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000549768","review_status":"no assertion criteria provided","trait_set_id":"8702","date_created":"2018-07-27","submitter_id":"506018","rcv_accession_id":"RCV000664336","submission_names":["MEN2 update May 2018"],"local_key":"6|MedGen:CN073359","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"549768"}
{"id":"SCV000711777","clinical_assertion_trait_set_id":"SCV000711777","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2016-04-14","version":"1","internal_id":"1392883","clinical_assertion_observation_ids":["SCV000711777.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000504895","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-04-03","submitter_id":"21766","rcv_accession_id":"RCV000614433","submission_names":["SUB5348977"],"local_key":"66138958|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"c.2232+9C\u003eT in intron 18 of MYH14: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"504895"}
{"id":"SCV000190379","clinical_assertion_trait_set_id":"SCV000190379","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},\"Comment\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyDescription\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyName\":{\"$\":\"ESP 6500 variant annotation\"}}","submission_id":"505295.2014-08-28","interpretation_date_last_evaluated":"2014-06-01","version":"1","internal_id":"347842","clinical_assertion_observation_ids":["SCV000190379.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"no assertion criteria provided","trait_set_id":"2675","date_created":"2014-12-04","submitter_id":"505295","rcv_accession_id":"RCV000035406","submission_names":["ESP 6500 variant annotation"],"local_key":"UWMG_1586863","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000604327","clinical_assertion_trait_set_id":"SCV000604327","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2019-04-07","version":"3","internal_id":"1168023","clinical_assertion_observation_ids":["SCV000604327.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-09-27","submitter_id":"25969","rcv_accession_id":"RCV001000015","submission_names":["Aug 2019 ARUP"],"local_key":"118047|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant (rs375882485) is a well-known causative variant reported in multiple individuals with hypertrophic cardiomyopathy (HCM; Richard 2003, Maron 2008, Kaski 2012, and Lopez 2013), and shown to segregate with disease in at least one affected family (Camuglia 2013). In one large study, the p.Arg502Trp variant was identified in 2.4% of Caucasian HCM patients (Saltzman 2010). This variant was also found at 1.4% in 6179 individuals diagnosed with HCM (Walsh 2017). Nuclear magnetic resonance studies indicate that p.Arg502Trp may impair important electrostatic interactions between MYBPC3 protein and other sarcomeric proteins (Zhang 2014). Thus, the p.Arg502Trp variant meets our criteria for classification as pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000606931","clinical_assertion_trait_set_id":"SCV000606931","content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"506185.2017-08-22","version":"1","internal_id":"1174093","clinical_assertion_observation_ids":["SCV000606931.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"no assertion provided","trait_set_id":"17368","date_created":"2017-10-13","submitter_id":"506185","rcv_accession_id":"RCV000203913","submission_names":["GenomeConnect_hg19_81817"],"local_key":"genomeconnect_15537_623","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.\"}"],"record_status":"current","interpretation_description":"not provided","variation_id":"42540"}
{"id":"SCV000280214","clinical_assertion_trait_set_id":"SCV000280214","submission_id":"505443.2016-05-06","interpretation_date_last_evaluated":"2014-07-08","version":"1","internal_id":"528700","clinical_assertion_observation_ids":["SCV000280214.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"no assertion criteria provided","trait_set_id":"9460","date_created":"2016-06-01","submitter_id":"505443","rcv_accession_id":"RCV000223898","submission_names":["5_6_2016"],"local_key":"NM_000256.3:c.1504C\u003eT|Not provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MYBPC3 p.Arg502Trp This variant has been reported in at least 37 cases of HCM, with strong segregation data. Richard et al (2003) reported this variant in one individual with HCM in their French cohort. Van Driest et al (2004) observed this variant in an HCM patient who also carried p.Gly5Arg in MYBPC3. Details regarding phase and the severity of phenotype were not reported for this patient However, a comparison of the 10 patients, including this one, with multiple variants to the patients with a single variant revealed that the multiple variant group had, on average, a more severe phenotype. Ingles et al (2005) reported observing this variant in one case of HCM. Saltzman et al (2010) reported p.Arg502Trp in 34 of 1414 (2.4%) unrelated cases of HCM, making it the most common variant in that cohort. Four families had another sarcomere variant and individuals with multiple variants were more likely to have severe clinical outcomes. They noted that ~50% of carriers of p.Arg502Trp had overt disease by age 45. They reported a combined Lod score of 4.04 and noted that the likelihood that the observed cosegregation happened by chance was 1/11,000. The highest number of family members cosegregating HCM and the variant in one individual family was three. Note that this paper includes a pedigree reported online by the Seidman group (pedigree FU). Morita et al (2008) observed the variant in two unrelated children with HCM. In one of those cases and affected parent also had the variant. One of these children also carried p.Ser858Asn in MYBPC3 (phase not reported) Note that these families may have been included in the subsequent report by Saltzman et al. Liu et al (2006) reported a Chinese patient with HCM who carried both p.Arg502Trp and IVS27+12C\u003eT, also in MYBPC3. The arginine at codon 502 is highly conserved across species. This mutation results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan. In silico analysis with PolyPhen-2 predicts the variant to be probably damaging. Another variant at the same codon has been reported in association with HCM (p.Arg502Gln, which we consider very likely disease causing), as have variants in nearby codons (p.Arg495Gln, p.Lys505del, p.Gly507Arg). In total the variant has not been seen in ~395 published controls, including 100 (Richard et al 2003), 200 (van Driest et al 2004), 95 (Saltzman et al 2010). The variant was observed in 1 of 3472 Caucasians and 0 of 1826 African Americans in the NHLBI Exome Sequence Project dataset (as of 7/8/2014). Individual phenotypes from that dataset are not available. Several different cohorts from studies on common complex cardiovascular disease were pooled to create that sample. There is no variant at codon 502 listed in dbSNP or 1000 genomes (as of 7/8/2014).\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000803346","clinical_assertion_trait_set_id":"SCV000803346","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"StudyName\":{\"$\":\"AGHI_GT\"}}","submission_id":"505530.2020-03-06","interpretation_date_last_evaluated":"2019-12-30","version":"3","internal_id":"1566231","clinical_assertion_observation_ids":["SCV000803346.0","SCV000803346.1","SCV000803346.2","SCV000803346.3","SCV000803346.4"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"2365","date_created":"2018-08-10","submitter_id":"505530","rcv_accession_id":"RCV000677196","submission_names":["SUB6906800"],"local_key":"11:47364249:G","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000208031","clinical_assertion_trait_set_id":"SCV000208031","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2019-01-29","interpretation_date_last_evaluated":"2018-12-31","version":"11","internal_id":"373680","clinical_assertion_observation_ids":["SCV000208031.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2015-02-19","submitter_id":"26957","rcv_accession_id":"RCV000223898","submission_names":["SUB5098196"],"local_key":"GDX:41434|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The R502W pathogenic variant in the MYBPC3 gene has been reported multiple times in association with HCM (Richard et al., 2003; Van Driest et al., 2004; Ingles et al., 2005; Saltzman et al., 2010; Page et al., 2012; Lopes et al., 2013). This variant has also been observed in multiple unrelated individuals tested for HCM at GeneDx. Richard et al. (2003) identified the R502W variant in one patient with HCM and it was not present in 200 control chromosomes. This study also considered R502 a hot spot\\\" for pathogenic variants because another variant affecting the same residue (R502Q) has also been associated with HCM (Richard et al., 2003; Niimura et al., 1998). Ingles et al. (2005) and Van Driest et al. (2004) observed the R502W variant in one HCM patient each, and the latter publication indicated R502W was not observed in 400 normal control alleles. Page et al. (2012) identified the R502W variant in nine families with HCM, in which variable penetrance and expressivity was observed. This pathogenic variant is observed at a low frequency in large population cohorts, reported in 13/126,700 (0.01%) alleles from individuals of European (non-Finnish) ancestry (Lek et al., 2016). R502W results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan residue at a position that is highly conserved across species. Functional studies by Zhang et al. (2014) suggested that R502W alters the electrostatic properties of the C3 domain which may disrupt the interaction with other sarcomeric proteins.\\\"\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000614141","clinical_assertion_trait_set_id":"SCV000614141","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25637381\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23299917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24055113\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}}]}}","submission_id":"1012.2017-08-17","interpretation_date_last_evaluated":"2016-12-16","version":"1","internal_id":"1197795","clinical_assertion_observation_ids":["SCV000614141.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-12-14","submitter_id":"1012","rcv_accession_id":"RCV000223898","submission_names":["SUB2963629"],"local_key":"NM_000256.3:c.1504C\u003eT|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"42540"}
{"id":"SCV000840016","clinical_assertion_trait_set_id":"SCV000840016","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"500199.2018-06-14","interpretation_date_last_evaluated":"2017-05-11","version":"1","internal_id":"1637569","clinical_assertion_observation_ids":["SCV000840016.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"2365","date_created":"2018-10-11","submitter_id":"500199","rcv_accession_id":"RCV000677196","submission_names":["SUB4151980"],"local_key":"NM_000256.3:c.1504C\u003eT|OMIM:115197","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This c.1504C\u003eT (p.Arg502Trp) variant has been reported in multiple patients with hypertrophic cardiomyopathy (HCM) [PMID 1270723, 22589294, 23396983, 20378854, 23642604]. The variant was detected in 34 individuals from a large study of 1,414 unrelated HCM patients [PMID 20378854]. From this study, it was estimated that this variant conveys a 340-fold increased risk for HCM by 45 years and the clinical prognosis worsens when this c.1504C\u003eT (p.Arg502Trp) change occurs in the setting of a pathogenic variant in another sarcomere protein gene [PMID 20378854]. This variant is common among HCM patients, occurring in an estimated 2.4% of patients [PMID 20378854]. This variant was reported in 3 heterozygous individuals in the ExAC database (http://exac.broadinstitute.org/variant/11-47364249-G-A). Arginine at position 502 of the MYBPC3 protein is highly conserved in mammals. While not validated for clinical use, computer-based algorithms predict this p.Arg502Trp change to be deleterious. This variant is thus classified as pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000059054","clinical_assertion_trait_set_id":"SCV000059054","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}}]},\"ReplacedList\":{\"Replaced\":{\"@Accession\":\"SCV000198910\",\"@DateChanged\":\"2015-02-23\",\"@Version\":\"1\"}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2011-06-16","version":"5","internal_id":"100254","clinical_assertion_observation_ids":["SCV000059054.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"17368","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000203913","submission_names":["SUB5348977"],"local_key":"2991309|Orphanet:ORPHA217569","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant in MYBPC3 has been well reported in many individuals acr oss multiple studies and is known to be pathogenic for hypertrophic cardiomyopat hy (HCM). It is also the most common pathogenic HCM variant identified by our la boratory. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant HCM based upon multiple reports in affected individuals and extensive segregation studies (Richard 2003, Van Driest 2004, Carballo 2005, Ingles 2005, Maron 2008, Kaski 2009, Marston 2009, Saltzman 2010). ACMG/AMP cri teria applied: PS4, PP1_Strong.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000319017","clinical_assertion_trait_set_id":"SCV000319017","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24793961\",\"@Source\":\"PubMed\"}}]}}","submission_id":"61756.2020-02-26","interpretation_date_last_evaluated":"2018-06-18","version":"4","internal_id":"600711","clinical_assertion_observation_ids":["SCV000319017.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"32616","date_created":"2016-09-29","submitter_id":"61756","rcv_accession_id":"RCV000252398","submission_names":["NonExomeUpdate_101019AmbryReport"],"local_key":"a83323","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Rarity in general population databases (dbsnp, esp, 1000 genomes);In silico models in agreement (deleterious) and/or completely conserved position in appropriate species;Deficient protein function in appropriate functional assay(s);Other strong data supporting pathogenic classification;Strong segregation with disease (lod \u003e3 = \u003e10 meioses);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Well-characterized mutation at same position\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000692517","clinical_assertion_trait_set_id":"SCV000692517","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Agnes Ginges Centre for Molecular Cardiology criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/djgybgii/mdi-5363_505375_agnesginges_variantassess_clinvar.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23690394\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21839045\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22563033\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24810389\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18761664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20818890\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27532257\",\"@Source\":\"PubMed\"}}]}}","submission_id":"505375.2017-12-19","interpretation_date_last_evaluated":"2017-03-16","version":"1","internal_id":"1353547","clinical_assertion_observation_ids":["SCV000692517.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"6411","date_created":"2018-02-23","submitter_id":"505375","rcv_accession_id":"RCV000584810","submission_names":["SUB3353316"],"local_key":"VAR0000100|OMIM:192600","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The MYBPC3 Arg502Trp s a well known cause of HCM, being reported in multiple HCM cases worldwide and segregating with HCM in families (see Ross et al. Circulation CV Genetics, 2017). The variant is present in the Exome Aggregation Consortium dataset (MAF=0.000025; http://exac.broadinstitute.org/). We have identified this variant in 14 HCM families with some segregation data (total of 7 meiosis). Computational tools SIFT, PolyPhen-2 and MutationTaster predict this variant to be deleterious. In summary, based on segregation, extensive reports of HCM cases with the variant and rarity in the general population, we classify MYBPC3 Arg502Trp as \\\"Pathogenic\\\".\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000260968","clinical_assertion_trait_set_id":"SCV000260968","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9562578\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22386539\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2019-12-30","version":"8","internal_id":"485953","clinical_assertion_observation_ids":["SCV000260968.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"17368","date_created":"2016-01-29","submitter_id":"500031","rcv_accession_id":"RCV000203913","submission_names":["SUB6933801"],"local_key":"78346|MedGen:C0007194","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces arginine with tryptophan at codon 502 of the MYBPC3 protein (p.Arg502Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs375882485, ExAC 0.01%). This variant has been shown to segregate with hypertrophic cardiomyopathy in more than ten families in the literature, and has been observed in many unrelated hypertrophic cardiomyopathy patients across multiple studies (PMID: 12707239, 20378854, 22267749, 23396983). ClinVar contains an entry for this variant (Variation ID: 42540). A different missense substitution at this codon (p.Arg502Gln) has been reported to segregate with disease in families affected with hypertrophic cardiomyopathy (PMID: 9562578, 22386539). This indicates that the Arg502 residue is important for MYBPC3 protein function. For these reasons, this variant has been classified as Pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000696313","clinical_assertion_trait_set_id":"SCV000696313","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18409188\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15115610\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15166115\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19293840\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500026.2018-01-25","interpretation_date_last_evaluated":"2016-07-26","version":"1","internal_id":"1362665","clinical_assertion_observation_ids":["SCV000696313.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"32616","date_created":"2018-03-15","submitter_id":"500026","rcv_accession_id":"RCV000252398","submission_names":["2016-2017-variants"],"local_key":"NM_000256.3:c.1504C\u003eT|MedGen:CN230736","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: The MYBPC3 c.1504C\u003eT (p.Arg502Trp) variant involves the alteration of a conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 3/122664 control chromosomes at a frequency of 0.0000245, which does not exceed the estimated maximal expected allele frequency of a pathogenic MYBPC3 variant (0.0010005). This variant has been reported in numerous HCM patients, with evidence of co-segregation of variant with disease in some of the families. Structure study predicted the R502W mutation and other HCM-linked mutations found within the same C3 domain, may directly disrupt the interaction of cMyBP-C with other sarcomeric proteins (Zhang_2014). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. It is the most common pathogenic HCM variant identified by our laboratory. Taken together, this variant is classified as pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000862304","clinical_assertion_trait_set_id":"SCV000862304","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MYBPC3\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29121657\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2018-07-10","version":"1","internal_id":"1679294","clinical_assertion_observation_ids":["SCV000862304.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-12-11","submitter_id":"500060","rcv_accession_id":"RCV000223898","submission_names":["SUB4534263"],"local_key":"71108_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
{"id":"SCV000372355","clinical_assertion_trait_set_id":"SCV000372355","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"685877","clinical_assertion_observation_ids":["SCV000372355.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"19227","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000351173","submission_names":["ICSL_2016Q4"],"local_key":"786202|Left Ventricular Noncompaction Cardiomyopathy","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"42540"}
{"id":"SCV000372356","clinical_assertion_trait_set_id":"SCV000372356","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"685878","clinical_assertion_observation_ids":["SCV000372356.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"33381","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000403323","submission_names":["ICSL_2016Q4"],"local_key":"786202|Dilated Cardiomyopathy, Dominant","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"42540"}
{"id":"SCV000372357","clinical_assertion_trait_set_id":"SCV000372357","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}}]}}","submission_id":"504895.2019-02-01","interpretation_date_last_evaluated":"2018-05-07","version":"3","internal_id":"685879","clinical_assertion_observation_ids":["SCV000372357.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000042540","review_status":"criteria provided, single submitter","trait_set_id":"33478","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000778104","submission_names":["SUB5118208"],"local_key":"792361","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The MYBPC3 c.1504C\u003eT (p.Arg502Trp) missense variant is well documented as a pathogenic variant for hypertrophic cardiomyopathy (HCM). Across a selection of the available literature, the p.Arg502Trp variant has been identified in heterozygous state in at least 44 individuals diagnosed with HCM. Two of the individuals carried another variant in the MYBPC3 gene in a compound heterozygous state with the p.Arg502Trp variant, and another 11 carried an additional variant in either MYBPC3 or another sarcomere gene (Richard et al. 2003; Van Driest et al. 2004; Ingles et al. 2005; Maron et al. 2008; Marston et al. 2009; Saltzman et al. 2010; Kaski et al. 2012; Lopes et al. 2013; Camuglia et al. 2013). The Arg502Trp variant has also been reported in a heterozygous state in three individuals diagnosed with left ventricular noncompaction cardiomyopathy. One of the individuals was the son of a female proband with HCM who also carried the variant in a heterozygous state. The two other individuals were the brother and nephew of another proband with HCM who also carried the variant in a heterozygous state (Camuglia et al. 2013). The p.Arg502Trp variant was absent from 945 controls (Van Driest et al. 2004; Saltzman et al. 2010) and is reported at a frequency of 0.0001026 in the European (non-Finnish) population of the Genome Aggregation Database. The variant has been shown to segregate with disease in multiple families (Saltzman et al. 2010). Based on the collective evidence, the p.Arg502Trp variant is classified as pathogenic for MYBPC3-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"42540"}
